Skip to main content
letter
. 2012 Mar;56(3):1662–1663. doi: 10.1128/AAC.05850-11

Table 1.

MICs of β-lactams for E. coli MAS clinical isolate, E. coli TOJ53 strain harboring the natural blaKPC-2-positive plasmid pMAS from E. coli MAS, and E. coli J53 recipient strain

β-Lactama MIC for strain
E. coli MAS (KPC-2) E. coli J53 (pMAS) E. coli J53
Amoxicillin >256 >256 4
Amoxicillin + CLA 128 32 4
Ticarcillin >256 >256 2
Ticarcillin + CLA 256 >256 2
Piperacillin >256 128 1
Piperacillin + TZB >256 128 1
Cefuroxime >256 256 2
Ceftazidime 256 32 0.06
Cefotaxime 128 4 0.12
Cefepime 128 2 0.06
Cefoxitin 256 2 2
Aztreonam >256 8 0.06
Imipenem 8 2 0.06
Meropenem 16 1 0.03
Ertapenem 256 0.5 0.03
Ciprofloxacin >256 0.06 0.06
Gentamicin 64 4 0.12
Amikacin 64 4 0.12
Fosfomycin 0.25 0.06 0.06
Tetracycline 0.5 0.03 0.03
Tigecycline 0.25 0.03 0.03
Colistin 0.25 0.12 0.12
a

CLA, clavulanic acid; TZB, tazobactam (both at a concentration of 4 μg/ml).